GLP-1 medications are expensive, often exceeding $1,000 per month, and insurance coverage for off-label addiction use is uncertain
While no clinical trials have examined BPC-157 for hip conditions directly, extensive preclinical work on tendons, ligaments, and muscles provides strong mechanistic support for its application to hip problems
Protocol B: Low Maintenance (0.25 mg indefinite) This is the most conservative approach and stays within studied dose ranges during the taper
Whether the additional weight loss at 12mg justifies the higher dose depends on individual tolerability and side effect burden
Handle with appropriate safety protocols, as it is for use by qualified professionals in controlled environments.
The spray format delivers the same two peptides as the injectable blend vial but without requiring reconstitution, syringes, or injection procedures